• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Symic Bio Announces Results from SB-030 Trial americanpharmaceuticacreview
    November 03, 2017
    Symic Bio announced results from the Phase 1/2 SHIELD trial evaluating SB-030, a locally administered therapeutic, in patients with peripheral vascular disease undergoing angioplasty.
  • Peanut allergies? There’s a clinical trial looking to fix that pharmafile
    October 18, 2017
    Aimmune Therapeutics, a biotech company developing treatments for food allergies, announced that it has entered into a clinical trial collaboration with Regeneron and Sanofi to develop its AR101 treatment for peanut allergies.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service